Kinsale Capital/$KNSL
1D1W1MYTD1Y5YMAX
Capital at risk
About Kinsale Capital
Kinsale Capital Group Inc is an insurance holding company. The company is engaged in offering property, casualty, and specialty insurance products. It offers specialty insurance products for allied health, healthcare, life sciences, professional, and a public entity. The company operates in only one reportable segment which is the Excess and Surplus Lines Insurance segment, which includes commercial excess and surplus lines liability and property insurance products through its underwriting divisions. The company generates revenues in the form of premiums and investment income.
- Ticker
- $KNSL
- Sector
- Finance
- Primary listing
- NYSE
- Employees
- 716
- Headquarters
- Richmond, United States
- Website
- www.kinsalecapitalgroup.com
Kinsale Capital Metrics
BasicAdvanced
$8.5B
15.14
$24.64
0.90
$0.84
0.27%
Price and volume
Market cap
$8.5B
Beta
0.9
52-week high
$485.00
52-week low
$287.20
Average daily volume
232K
Dividend rate
$0.84
Financial strength
Current ratio
0.194
Quick ratio
0.086
Long term debt to equity
11.033
Total debt to equity
11.033
Dividend payout ratio (TTM)
3.40%
Interest coverage (TTM)
60.23%
Profitability
EBITDA (TTM)
732.259
Gross margin (TTM)
31.14%
Net profit margin (TTM)
28.49%
Operating margin (TTM)
36.33%
Effective tax rate (TTM)
20.26%
Revenue per employee (TTM)
$2,790,000
Management effectiveness
Return on assets (TTM)
7.56%
Return on equity (TTM)
30.27%
Valuation
Price to earnings (TTM)
15.144
Price to revenue (TTM)
4.298
Price to book
4.18
Price to tangible book (TTM)
4.18
Price to free cash flow (TTM)
8.572
Free cash flow yield (TTM)
11.67%
Free cash flow per share (TTM)
43.535
Dividend yield (TTM)
0.23%
Forward dividend yield
0.27%
Growth
Revenue change (TTM)
15.82%
Earnings per share change (TTM)
28.61%
3-year revenue growth (CAGR)
24.71%
10-year revenue growth (CAGR)
33.55%
3-year earnings per share growth (CAGR)
35.74%
10-year earnings per share growth (CAGR)
45.37%
3-year dividend per share growth (CAGR)
15.87%
What the Analysts think about Kinsale Capital
Analyst ratings (Buy, Hold, Sell) for Kinsale Capital stock.
Analyst projections of the future price of Kinsale Capital stock.
Bulls say / Bears say
In the second quarter of 2026, Kinsale reported net operating earnings of $126.2 million, or $5.54 per diluted share, up from $111.4 million, $4.78 per diluted share in Q2 2025, underscoring disciplined underwriting and expense management. (Business Wire)
In February 2026, the Board raised the quarterly dividend by 47.1% to $0.25 per share, reflecting strong capital generation and commitment to shareholder returns. (Zacks)
In December 2025, Kinsale authorized a $250 million share repurchase program, signaling management’s confidence in the company’s valuation and prospects while boosting EPS potential. (SEC)
Continued premium contraction in Kinsale’s large commercial property division, driven by fierce competition and falling rates for catastrophe-exposed accounts, has moderated gross written premium growth. (Benzinga)
After‐tax catastrophe losses rose to $24.0 million in 2025 from $20.2 million in 2024, highlighting the business’s exposure to loss volatility. (Business Wire)
U.S. excess & surplus property premium volumes declined double-digit in mid-2026 as new capacity softened rates, posing top-line pressure for Kinsale’s E&S property-focused operations. (Insurance Business)
Data summarised monthly by Lightyear AI. Last updated on 20 Aug 2026.
Kinsale Capital Financial Performance
Revenues and expenses
Kinsale Capital Earnings Performance
Company profitability
Upcoming events
Kinsale Capital News
AllArticlesVideos
Funds containing Kinsale Capital
AllUSDGBPEUR
Fund name | Fund size | $KNSL weighting |
|---|---|---|
SPDR S&P 400 US Mid Cap$SPY4 | $6.4B | 0.23% |
SPDR S&P 400 US Mid Cap£SPX4 | £4.7B | 0.23% |
iShares MSCI USA Small Cap ESG Enhanced CTB€SXRG | €2.8B | 0.12% |
iShares MSCI USA Small Cap CTB Enhanced ESG£CUS1 | £2.4B | 0.12% |
iShares MSCI World Small Cap$WSML | $9B | 0.08% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.